The company reported a quarterly revenue miss of $4.05M, missing analyst expectations amid broader market challenges. MarketWise reported a quarterly loss of $0.23 per share on revenue of $77.03M, missing estimates by $4.05M. The shortfall reflects weaker-than-expected dem
The cloud monitoring firm reported adjusted earnings of 43 cents per share, exceeding analyst expectations of 38 cents. Datadog posted first-quarter adjusted earnings of 43 cents per share, surpassing the 38-cent consensus estimate. Revenue climbed 25% year-over-year to $6
The company’s Q2 revenue guidance exceeds analyst expectations, driving a sharp rise in its stock price. Unity Software Inc. (U) shares jumped after the company issued stronger-than-expected Q2 revenue guidance. The forecast reflects accelerating demand for its game develo
The biotech firm reported quarterly earnings per share of $0.24 and revenue of $106.5 million, aligning with expectations. Ironwood Pharmaceuticals reported non-GAAP earnings per share of $0.24 and revenue of $106.5 million for the quarter. The results met analyst estimate
Lantheus Holdings exceeded Q2 earnings and revenue forecasts, driven by stronger-than-expected demand for its medical imaging products. Lantheus Holdings reported Q2 non-GAAP earnings per share of $1.46, beating estimates by $0.23, as revenue reached $377.3M, $22.88M above
Dow posts recovery since April The US president has been closely watching the stock market performance. The Dow has seen a remarkable recovery in market sentiment since April. The president's latest tweet included an image snapshot of the Dow closing level
The burger chain reported a GAAP EPS of $0.00, missing estimates by $0.14, as revenue declined $5.57M below forecasts. Shake Shack posted a GAAP earnings per share of $0.00 for the quarter, missing analyst expectations by $0.14. Revenue reached $366.7M, falling short of pr
The software company exceeded analyst expectations for both earnings per share and quarterly revenue in its latest report. Appian reported non-GAAP earnings per share of $0.27, surpassing estimates by $0.09. Revenue reached $202.18M, beating projections by $10.43M.
The biopharmaceutical firm reported a $0.17 miss on non-GAAP EPS and a $7.14M revenue shortfall for the quarter. Ligand Pharmaceuticals posted a non-GAAP EPS of $1.63, missing estimates by $0.17, as revenue reached $51.72M, $7.14M below expectations. The results reflect we
The egg producer reported a GAAP loss of $0.03 per share while revenue of $187.2M exceeded expectations by $4.83M. Vital Farms posted a GAAP loss of $0.03 per share for the quarter, missing estimates by $0.08. Revenue reached $187.2M, surpassing forecasts by $4.83M. <p
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.